A systematic review was performed in Medline®, Embase®, Scopus®, CINAHL®, CENTRAL® and PsycInfo® in accordance to the PRISMA and SWiM checklists. Randomised controlled trials (RCTs) which evaluated the use of MBI among adult CKD patients were included. The efficacy of each MBI was determined by reduction in symptoms severity scores. All adverse reactions were documented.
Of the 7,417 articles screened, 32 RCTs were included. Music therapy (n = 11), relaxation therapy (n = 9) and spiritual therapy (n = 6) were the most well studied MBIs. Frequently studied indications for MBIs were anxiety symptoms (n = 12), pain (n = 7) and depressive symptoms (n = 5). Music and spiritual therapies were shown to reduce 8.06 – 43.5% and 36.1- 41.1% of anxiety symptoms respectively. For pain relief, music (41.8% – 61.5%) and yoga therapies (36.7%) were shown to be effective for reduction of pain. Lastly, spiritual therapy was shown to reduce depressive symptoms by 56.8%. No adverse effects were reported for any MBI.
Music therapy, relaxation and spiritual therapies are more well-studied MBIs for CKD and promising in reducing anxiety, depressive symptoms and pain. Larger RCTs are required to confirm the efficacy and safety of promising MBIs.
Copyright © 2020. Published by Elsevier Ltd.